AVAS 2019 Session I

Question 1 / 9

🏆 Rank #-- ▾

Score 0/100

1. A 70yo man with a long history of smoking presents with shortness of breath and is found to have a new left lower lobe mass as well as a large left pleural effusion. Which of the following statement is true regarding malignant pleural effusions?

Malignant pleural effusions tend to be void of immune cells.

Adoptive T cell transfer utilizes T cells from a mouse to combat cancer in a human.

Once immune cells are removed from a tumor microenvironment, they are no longer able to be activated.

About This Quiz

AVAS Session 1, Saturday April 27, 2019

2. What first name or nickname would you like us to use?

You may optionally provide this to label your report, leaderboard, or certificate.

2. Preoperative Decontamination consists of using which agents?

Chloraprep

Duraprep

Chlorhexidine Washcloths

Dial Soap

3. Does pre-operative health-related quality of life (HRQoL) impact five-year post-coronary artery bypass graft (CABG) mortality?

Yes, but only on univariate analysis

Yes, but only for patients with no other co morbidity

Yes, it is an independent predictor of 5-year survival after controlling for other factors

No, it is not a predictor of long term mortality

4. Which combination of exposures confers the highest adjusted risk of long-term, all-cause mortality following major general or vascular operations?

CVD only

ESRD only

Stage 4 CKD in the presence of CVD

Stage 5 CKD in the presence of CVD

5. Which of the following is NOT a LEAN methodology technique?

Mapping of Current State

Mapping of Ideal State

Force Function

Trial and Error

6. Which of the following conditions is NOT associated with the diagnosis of Cardiometabolic syndrome?

Diabetes

Coronary Artery Disease

Hypertension

Obesity

7. Cluster randomized trials are randomized at the level of the _____:

Patient

Site

Procedure

Day

8. The most common pathogenic/likely pathogenic variant identified in patients with pancreatic cancer was ______?

BRCA1

BRCA2

ATM

PALB2

Thank you for your feedback!

Avas 2019 Session I